Altimmune Inc (ALT)
Healthcare
Biotechnology
3.00 $
+5.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Altimmune Inc (ALT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -21 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 | -20 | -17 | -16 | -18 | -27 | -18 | -17 | -19 | -12 | -19 | -21 | -72 | |
| 0.1 | -0.6 | 1.9 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 2.8 | 2.7 | 2.5 | 3.7 | 4.3 | 3.1 | 3.4 | 4.0 | 3.6 | 3.6 | 4.9 | 3.4 | 15 | |
| 2.7 | 2.7 | – | – | – | – | – | – | – | – | – | – | – | |
| -5.5 | -2.0 | 0.8 | 5.3 | 3.2 | -8.4 | 2.5 | 0.1 | -0.5 | 3.5 | 3.6 | -2.0 | 4.7 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 4.0 | 4.4 | -8.0 | -40 | -3.7 | 1.2 | 14 | -5.1 | 101 | -149 | -79 | -3.7 | -131 | |
| -0.5 | 0.0 | 0.0 | -0.6 | -0.2 | 1.1 | – | 0.2 | – | 0.1 | – | 0.2 | – | |
| – | – | – | – | – | 0.0 | – | – | – | 0.0 | 20 | – | – | |
| 13 | 0.6 | 73 | -0.3 | 0.0 | 0.3 | 10 | 34 | 52 | 39 | 81 | 78 | 251 | |
| -2.3 | -15 | 48 | -56 | -22 | -26 | 5.5 | 12 | 134 | -122 | -17 | 54 | 48 | |
| -20 | -20 | -17 | -16 | -18 | -27 | -18 | -17 | -19 | -12 | -19 | -21 | -72 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.